Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
705 | 3079 | 43.5 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
540 | 13989 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TOPOISOMERASE II | Author keyword | 88 | 33% | 7% | 222 |
2 | ICRF 193 | Author keyword | 47 | 81% | 1% | 29 |
3 | DNA TOPOISOMERASE II | Author keyword | 42 | 47% | 2% | 67 |
4 | HUMAN TOPOISOMERASE I | Author keyword | 42 | 94% | 0% | 15 |
5 | DNA TOPOISOMERASE I | Author keyword | 37 | 43% | 2% | 67 |
6 | TOPOISOMERASE I | Author keyword | 35 | 24% | 4% | 127 |
7 | TOPOISOMERASE II BETA | Author keyword | 27 | 70% | 1% | 23 |
8 | TOPOISOMERASE II ALPHA | Author keyword | 26 | 31% | 2% | 71 |
9 | TOPOISOMERASE | Author keyword | 26 | 20% | 4% | 114 |
10 | F 11782 | Author keyword | 20 | 100% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TOPOISOMERASE II | 88 | 33% | 7% | 222 | Search TOPOISOMERASE+II | Search TOPOISOMERASE+II |
2 | ICRF 193 | 47 | 81% | 1% | 29 | Search ICRF+193 | Search ICRF+193 |
3 | DNA TOPOISOMERASE II | 42 | 47% | 2% | 67 | Search DNA+TOPOISOMERASE+II | Search DNA+TOPOISOMERASE+II |
4 | HUMAN TOPOISOMERASE I | 42 | 94% | 0% | 15 | Search HUMAN+TOPOISOMERASE+I | Search HUMAN+TOPOISOMERASE+I |
5 | DNA TOPOISOMERASE I | 37 | 43% | 2% | 67 | Search DNA+TOPOISOMERASE+I | Search DNA+TOPOISOMERASE+I |
6 | TOPOISOMERASE I | 35 | 24% | 4% | 127 | Search TOPOISOMERASE+I | Search TOPOISOMERASE+I |
7 | TOPOISOMERASE II BETA | 27 | 70% | 1% | 23 | Search TOPOISOMERASE+II+BETA | Search TOPOISOMERASE+II+BETA |
8 | TOPOISOMERASE II ALPHA | 26 | 31% | 2% | 71 | Search TOPOISOMERASE+II+ALPHA | Search TOPOISOMERASE+II+ALPHA |
9 | TOPOISOMERASE | 26 | 20% | 4% | 114 | Search TOPOISOMERASE | Search TOPOISOMERASE |
10 | F 11782 | 20 | 100% | 0% | 9 | Search F+11782 | Search F+11782 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DNA TOPOISOMERASE | 106 | 44% | 6% | 183 |
2 | EUKARYOTIC TOPOISOMERASE | 105 | 65% | 3% | 100 |
3 | ANTITUMOR DRUGS | 100 | 35% | 8% | 236 |
4 | DNA TOPOISOMERASES | 87 | 33% | 7% | 218 |
5 | BIS2 6 DIOXOPIPERAZINE DERIVATIVES | 84 | 68% | 2% | 73 |
6 | ACTIVE SITE TYROSINE | 53 | 70% | 1% | 44 |
7 | CAMPTOTHECIN RESISTANCE | 52 | 72% | 1% | 41 |
8 | CAMPTOTHECIN | 51 | 15% | 10% | 318 |
9 | TARGETED DRUGS | 47 | 66% | 1% | 43 |
10 | CATALYTIC INHIBITORS | 37 | 74% | 1% | 28 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
DNA topoisomerases | 1996 | 1684 | 496 | 58% |
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs | 2010 | 305 | 105 | 51% |
Drugging Topoisomerases: Lessons and Challenges | 2013 | 96 | 137 | 45% |
DNA topoisomerases: Structure, function, and mechanism | 2001 | 1280 | 184 | 34% |
Targeting DNA topoisomerase II in cancer chemotherapy | 2009 | 354 | 156 | 48% |
Cellular roles of DNA topoisomerases: A molecular perspective | 2002 | 1137 | 111 | 28% |
Topoisomerase I inhibitors: camptothecins and beyond | 2006 | 648 | 140 | 35% |
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice | 2000 | 212 | 239 | 81% |
DNA TOPOISOMERASES - ESSENTIAL ENZYMES AND LETHAL TARGETS | 1994 | 602 | 149 | 59% |
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme | 1998 | 342 | 147 | 90% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | G MORUZZI BIOCHEM | 6 | 50% | 0.3% | 8 |
2 | INTER ONCOL | 4 | 67% | 0.1% | 4 |
3 | BIOL PHARMACOL DNA TOPOISOMERASES | 3 | 57% | 0.1% | 4 |
4 | BIOSTRUCT BIOSYST INBB | 3 | 45% | 0.2% | 5 |
5 | REG CANC TREATMENT SERV | 3 | 60% | 0.1% | 3 |
6 | MED MYCOL SHOWA KU | 2 | 36% | 0.2% | 5 |
7 | CANC TREATMENT MOLEC PHARMACOL | 2 | 67% | 0.1% | 2 |
8 | EXPT CANCEROL 1 | 2 | 67% | 0.1% | 2 |
9 | BIOSTRUCT GRP | 2 | 21% | 0.2% | 7 |
10 | MOLEC PHARMACOL | 1 | 13% | 0.3% | 10 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200716 | DNA GYRASE//GYRASE//REVERSE GYRASE |
2 | 0.0000150330 | HEAT SHOCK PROTECTION//ADP RIBOSEPOLYMERASE//CHICKEN EMBRYO CELLS |
3 | 0.0000123116 | CAMPTOTHECIN//SN 38//TOPOTECAN |
4 | 0.0000096010 | AOA2//ARSACS//APRATAXIN |
5 | 0.0000083846 | EQUIPE ACCUEIL EA 3105//ESCHERICHIA COLI WP2UVRA PKM101//DIRECC INVEST ENSENANZA |
6 | 0.0000063598 | MERBARONE//SEZ CHIM FARMACO PRODOTTO COSMET//SQUAMOUS CELL CARCINOMA CERVIX |
7 | 0.0000063273 | PYRAZOLOACRIDINE//C 1311//IMIDAZOACRIDINONES |
8 | 0.0000058736 | ETOPOSIDE PHOSPHATE//ETOPOSIDE//ORAL ETOPOSIDE |
9 | 0.0000056211 | BENZOCPHENANTHRIDINE//INDENOISOQUINOLINE//3 ARYLISOQUINOLINE |
10 | 0.0000052642 | ELLIPTICINE//OLIVACINE//INTOPLICINE |